top of page

Welcome to Isozaki Lab!

Genome Biology

Isozaki Lab
Understanding Molecular Mechanisms of Cancer Evolution
to Prevent Drug Resistance and Cancer Development

News

News

Research

Our Mission

Our research laboratory is committed to developing innovative cancer therapies which prevent cancer progression.

​

We specifically aim to uncover novel insights into the role of APOBECs in promoting the evolution of cancers, leading to acquired drug resistance and cancer development. 

News

Latest Publications

Hideko Isozaki

Therapy-induced APOBEC3A drives evolution of persistent cancer cells
Isozaki, H. et al. Nature. 620, 393–401 (2023)

Our recent work showed that APOBEC3A promotes the evolution of persistent cancer cells during targeted therapy, facilitating acquired drug resistance. 

Events

Sunrise

2025 Hokkaido Cancer Association Symposium
Sapporo Medical University
Hokkaido University

 

Invited Speaker​

Hideko Isozaki

7/19/2025

Sapporo, Japan

2025 World Conference on Lung Cancer
International Association for the Study of Lung Cancer (IASLC)

Young Investigator

Grant Recipient

Hideko Isozaki

9/6 - 9/9/2025

Barcelona, Spain

2025 Basic Seminar in Okayama
Boehringer Ingelheim

 

Invited Speaker​

Hideko Isozaki

11/14/2025

Washington D.C.

Kanazawa University Cancer Research Institute

Isozaki Lab
- Genome Biology -

Copyright © Isozaki Lab. All Rights Reserved.

bottom of page